Almirincomb 8 mg/5 mg tablete
| Name | Almirincomb 8 mg/5 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-063616380 |
| Active Substance | perindopril-tert-butilamin amlodipinbesilat |
| Composition | jedna tableta sadrži 8 mg perindopril-tert-butilamina što odgovara 6,68 mg perindoprila i 5 mg amlodipina (u obliku besilata) |
| Pharmaceutical Form | tableta |
| Packaging [MA Number for Packaging] | 30 tableta u blisteru, u kutiji [HR-H-063616380-01] |
| Manufacturer | Adamed Pharma S.A., Pabianice, Poljska
Jadran Galenski laboratorij d.d., Rijeka, Hrvatska |
| Marketing Authorisation Holder | Jadran Galenski laboratorij d.d., Svilno 20, Rijeka, Hrvatska |
| Marketing Authorisation Date | 27.11.2019 |
| MA Period of Validity | 27.11.2024 |
| Classification Number | UP/I-530-09/18-01/96 |
| Registration Number | 381-12-01/70-19-08 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | C09BB04 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
